183 related articles for article (PubMed ID: 36058365)
1. Incidence and factors predictive of recurrent thrombosis in people with non-cirrhotic portal vein thrombosis.
Baiges A; Procopet B; Silva-Junior G; Llop E; Tellez L; Darnell A; Garcia-Criado Á; Turon F; Nicoara-Farcau O; González-Alayón C; Larrue H; Magaz M; Olivas P; Perez-Campuzano V; Calleja JL; Albillos A; Reverter JC; Bureau C; Bosch J; Hernández-Gea V; Garcia-Pagán JC; ; ;
J Hepatol; 2023 Jan; 78(1):114-122. PubMed ID: 36058365
[TBL] [Abstract][Full Text] [Related]
2. Next-generation sequencing in the diagnosis of non-cirrhotic splanchnic vein thrombosis.
Magaz M; Alvarez-Larrán A; Colomer D; López-Guerra M; García-Criado MÁ; Mezzano G; Belmonte E; Olivas P; Soy G; Cervantes F; Darnell A; Ferrusquía-Acosta J; Baiges A; Turon F; Hernández-Gea V; García-Pagán JC
J Hepatol; 2021 Jan; 74(1):89-95. PubMed ID: 32679300
[TBL] [Abstract][Full Text] [Related]
3. Recurrent splanchnic and extrasplanchnic thrombotic events in patients with non-cirrhotic portal vein thrombosis associated with local factors.
Ollivier-Hourmand I; Lebedel L; Alabau BB; Goria O; Bureau C; Dumortier J; Heurgué A; Silvain C; De-Ledinghen V; Rautou PE; Payancé A; Ballester TG; Alvarado-Tapias E; Hernández-Gea V; Valla D; Zekrini K; Nga Nguyen TT; Dao T; Garcia Pagan JC; Morello R; Plessier A
J Hepatol; 2024 Apr; ():. PubMed ID: 38679069
[TBL] [Abstract][Full Text] [Related]
4. Long-Term Outcome of Splanchnic Vein Thrombosis in Cirrhosis.
Senzolo M; Riva N; Dentali F; Rodriguez-Castro K; Sartori MT; Bang SM; Martinelli I; Schulman S; Alatri A; Beyer-Westendorf J; Di Minno MND; Ageno W;
Clin Transl Gastroenterol; 2018 Aug; 9(8):176. PubMed ID: 30108204
[TBL] [Abstract][Full Text] [Related]
5. Clinical predictors for thrombus progression in cirrhotic patients with untreated splanchnic vein thrombosis.
McMurry H; Sabile JMG; Elstrott B; Chobrutskiy B; Mohinani A; Patel S; Gowda S; Martens K; Shatzel J
Thromb Res; 2022 Aug; 216():1-7. PubMed ID: 35660708
[TBL] [Abstract][Full Text] [Related]
6. Anticoagulation and Vessel Recanalization in Cirrhotic Patients with Splanchnic Vein Thrombosis: A Multidisciplinary "Real Life" Experience.
Rupoli S; Fiorentini A; Morsia E; Svegliati-Baroni G; Micucci G; Maroni L; Garvey KB; Fiorentini A; Riva A; Da Lio L; Benedetti A; Offidani M; Olivieri A; Giuseppe T
Vasc Health Risk Manag; 2021; 17():619-629. PubMed ID: 34594107
[TBL] [Abstract][Full Text] [Related]
7. Therapeutic anticoagulation for splanchnic vein thrombosis in acute pancreatitis: A national survey and case-vignette study.
Sissingh NJ; Groen JV; Timmerhuis HC; Besselink MG; Boekestijn B; Bollen TL; Bonsing BA; Klok FA; van Santvoort HC; Verdonk RC; van Eijck CHJ; van Hooft JE; Mieog JSD
World J Gastroenterol; 2023 Jun; 29(21):3328-3340. PubMed ID: 37377583
[TBL] [Abstract][Full Text] [Related]
8. Incidence and outcomes of splanchnic vein thrombosis after diagnosis of COVID-19 or COVID-19 vaccination: a systematic review and meta-analysis.
Zheng X; Gao F; Wang L; Meng Y; Ageno W; Qi X
J Thromb Thrombolysis; 2023 Jan; 55(1):18-31. PubMed ID: 36402911
[TBL] [Abstract][Full Text] [Related]
9. Clinical history and antithrombotic treatment of incidentally detected splanchnic vein thrombosis: a multicentre, international prospective registry.
Riva N; Ageno W; Schulman S; Beyer-Westendorf J; Duce R; Malato A; Santoro R; Poli D; Verhamme P; Martinelli I; Kamphuisen P; Dentali F;
Lancet Haematol; 2016 Jun; 3(6):e267-75. PubMed ID: 27264036
[TBL] [Abstract][Full Text] [Related]
10. Outcomes of long-term anticoagulant treatment for the secondary prophylaxis of splanchnic venous thrombosis.
Serrao A; Merli M; Lucani B; Aprile F; Fiori L; Gioia S; Breccia M; Riggio O; Chistolini A
Eur J Clin Invest; 2021 Jan; 51(1):e13356. PubMed ID: 33180323
[TBL] [Abstract][Full Text] [Related]
11. Splanchnic venous thrombosis: aetiologies and a review of the literature.
Tan R; Daneshmand A; Parys S; Watanabe Y; Sieunarine K
ANZ J Surg; 2022 Sep; 92(9):2224-2228. PubMed ID: 35751848
[TBL] [Abstract][Full Text] [Related]
12. Thrombophilic genotypes, natural anticoagulants, and plasma homocysteine in myeloproliferative disorders: relationship with splanchnic vein thrombosis and arterial disease.
Amitrano L; Guardascione MA; Ames PR; Margaglione M; Antinolfi I; Iannaccone L; Annunziata M; Ferrara F; Brancaccio V; Balzano A
Am J Hematol; 2003 Feb; 72(2):75-81. PubMed ID: 12555209
[TBL] [Abstract][Full Text] [Related]
13. Splanchnic vein thrombosis in candidates for liver transplantation: usefulness of screening and anticoagulation.
Francoz C; Belghiti J; Vilgrain V; Sommacale D; Paradis V; Condat B; Denninger MH; Sauvanet A; Valla D; Durand F
Gut; 2005 May; 54(5):691-7. PubMed ID: 15831918
[TBL] [Abstract][Full Text] [Related]
14. Prevalence of prothrombotic factors in patients with Budd-Chiari syndrome or non-cirrhotic nonmalignant portal vein thrombosis: A hospital-based observational study.
Fan J; Wang Q; Luo B; Chen H; Wang Z; Niu J; Yuan J; Yuan X; Bai W; He C; Guo W; Li K; Yin Z; Fan D; Han G
J Gastroenterol Hepatol; 2020 Jul; 35(7):1215-1222. PubMed ID: 31711259
[TBL] [Abstract][Full Text] [Related]
15. How to manage splanchnic vein thrombosis in patients with liver disease.
Riva N; Ageno W
Hematology Am Soc Hematol Educ Program; 2023 Dec; 2023(1):281-288. PubMed ID: 38066910
[TBL] [Abstract][Full Text] [Related]
16. Association of Splanchnic Vein Thrombosis on Survival: 15-Year Institutional Experience With 1561 Cases.
Wells PS; Theberge I; Bowdridge J; Kelly E; Kielar A; Forgie MA; John S; van Walraven C
J Am Heart Assoc; 2020 Dec; 9(24):e016600. PubMed ID: 33269616
[TBL] [Abstract][Full Text] [Related]
17. Long-term Clinical Outcomes of Splanchnic Vein Thrombosis: Results of an International Registry.
Ageno W; Riva N; Schulman S; Beyer-Westendorf J; Bang SM; Senzolo M; Grandone E; Pasca S; Di Minno MN; Duce R; Malato A; Santoro R; Poli D; Verhamme P; Martinelli I; Kamphuisen P; Oh D; D'Amico E; Becattini C; De Stefano V; Vidili G; Vaccarino A; Nardo B; Di Nisio M; Dentali F
JAMA Intern Med; 2015 Sep; 175(9):1474-80. PubMed ID: 26168152
[TBL] [Abstract][Full Text] [Related]
18. Anticoagulation Therapy for Splanchnic Vein Thrombosis Associated With Acute Pancreatitis: A Systematic Review and Meta-Analysis.
Yin Y; Wang L; Gao F; Liu L; Qi X
Clin Appl Thromb Hemost; 2023; 29():10760296231188718. PubMed ID: 37461391
[TBL] [Abstract][Full Text] [Related]
19. Splanchnic vein thrombosis: Clinical manifestations, risk factors, management, and outcomes.
Kawata E; Siew DA; Payne JG; Louzada M; Kovacs MJ; Lazo-Langner A
Thromb Res; 2021 Jun; 202():90-95. PubMed ID: 33798804
[TBL] [Abstract][Full Text] [Related]
20. Survival after splanchnic vein thrombosis: A 20-year nationwide cohort study.
Søgaard KK; Darvalics B; Horváth-Puhó E; Sørensen HT
Thromb Res; 2016 May; 141():1-7. PubMed ID: 26945454
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
